[Positive interferon-gamma release assay and immunosuppression: guideline-based diagnosis and treatment of tuberculosis infection] [0.03%]
阳性γ-干扰素释放试验与免疫抑制剂的使用：基于指南的结核感染诊断和治疗
Carola Horn-Magar,Jonathan Steinke,Philipp Köhler et al.
Carola Horn-Magar et al.
With the growing use of immunosuppressive therapies, clinicians are increasingly faced with the question of how to manage positive interferon-gamma release assays (IGRA). A tuberculosis infection (TBI, formerly referred to as "latent tuberc...
[Aspects of palliative pharmacotherapy in geriatric patients: what is rational in the presence of severe frailty? : Shared decision-making as the basis for finding solutions] [0.03%]
姑息治疗中的老年患者用药：严重衰弱患者合理用药的基础是共同决策
Achim Rehlaender,E V Pfeiffer
Achim Rehlaender
Difficulties with polypharmacy are a recognized problem in geriatric patients suffering from multimorbidity. Clinical science has developed several solutions to this problem. The most widely endorsed approach is the use of medication lists,...
Marlena Schnieder,Christine A F von Arnim
Marlena Schnieder
Dementia, delirium, and depression are the main geriatric psychiatric syndromes, and their prevalence is increasing significantly due to demographic aging. At the same time, multimorbidity and polypharmacy lead to increased interaction rate...
David Czock,Kathrin Ebinger,Claudia Sommerer
David Czock
Background: Polypharmacy is common among older adults. Renal effects can range from mild functional increases in creatinine to structural tubular injury. ...
[The future of endoscopy] [0.03%]
[内镜的未来]
Julia Mayerle,Riccardo Vasapolli
Julia Mayerle
Jasmin Tischer,Nadine Dietze,Kathrin Marx et al.
Jasmin Tischer et al.
Increasing antimicrobial resistance (AMR) is one of the greatest threats to global health. In 2021, 4.71 million deaths worldwide were closely associated with AMR, and 1.14 million deaths could be directly attributed to infections caused by...
[Paradigm shift in the first-line treatment of BRAF V600E-mutated metastatic colorectal cancer : BREAKWATER-Trial] [0.03%]
【BRAF V600E突变型转移性结直肠癌一线治疗的范式转变：BREAKWATER研究】
Mirjam Richard,Sirka Nitschmann,Christine Koch
Mirjam Richard
[Inhibition of cholesteryl ester transfer protein (CETP) with obicetrapib to reduce cardiovascular risk : BROADWAY Trial] [0.03%]
obicetrapib通过抑制胆固醇酯转运蛋白以降低心血管风险的Broadway试验
Maximilian Seidel,Sirka Nitschmann,Timm H Westhoff
Maximilian Seidel